Applied Clinical Trials-01-01-2002

Whether formally accrediting IRBs will benefit research subjects?or simply create more paperwork?remains to be seen.

European Parliament debates on the allocation of research funds reveals Euro-MPs views of clinical research in medicines development.

Efforts to ensure the safety and integrity of clinical trials will generate new standards and expand oversight initiatives.

Addressing the unnacceptable lack of pediatric labeling requires not only economic incentives but also an understanding of the unique difficulties involved in pediatric studies.